# Mycophenolate-Based Therapy for Kidney Transplant Recipients Without HLA-DQ Mismatch

> **NCT06493526** · PHASE4 · RECRUITING · sponsor: **University Hospital, Antwerp** · enrollment: 20 (estimated)

## Conditions studied

- Kidney Transplantation

## Interventions

- **DRUG:** Withdrawal of calcineurin-inhibitor, continue on concentration-controlled mycophenolate mofetil and corticosteroids.

## Key facts

- **NCT ID:** NCT06493526
- **Lead sponsor:** University Hospital, Antwerp
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-08-20
- **Primary completion:** 2026-12-31
- **Final completion:** 2027-06-30
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2024-08-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06493526

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06493526, "Mycophenolate-Based Therapy for Kidney Transplant Recipients Without HLA-DQ Mismatch". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06493526. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*